ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas

被引:10
作者
Mah, Vei [1 ]
Elshimali, Yahya [3 ]
Chu, Alison [2 ]
Moatamed, Neda A. [1 ]
Uzzell, Jamar P. [1 ]
Tsui, Jessica [1 ]
Schettler, Stephen [1 ]
Shakeri, Hania [1 ]
Wadehra, Madhuri [1 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, MacDonald Res Labs 4525, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA
[3] Charles R Drew Univ Med & Sci, Dept Med, Div Canc Res & Training, 1621 E 120th St, Los Angeles, CA 90059 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
关键词
STEM-CELLS; BREAST-CANCER; ALDEHYDE DEHYDROGENASES; CLASSIFICATION; PROGNOSIS;
D O I
10.1038/s41598-021-90570-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In type 1 endometrial cancer, unopposed estrogen stimulation is thought to lead to endometrial hyperplasia which precedes malignant progression. Recent data from our group and others suggest that ALDH activity mediates stemness in endometrial cancer, but while aldehyde dehydrogenase 1 (ALDH1) has been suggested as a putative cancer stem cell marker in several cancer types, its clinical and prognostic value in endometrial cancer remains debated. The aim of this study was to investigate the clinical value of ALDH1 expression in endometrial hyperplasia and to determine its ability to predict progression to endometrial cancer. Interrogation of the TCGA database revealed upregulation of several isoforms in endometrial cancer, of which the ALDH1 isoforms collectively constituted the largest group. To translate its expression, a tissue microarray was previously constructed which contained a wide sampling of benign and malignant endometrial samples. The array contained a metachronous cohort of samples from individuals who either developed or did not develop endometrial cancer. Immunohistochemical staining was used to determine the intensity and frequency of ALDH1 expression. While benign proliferative and secretory endometrium showed very low levels of ALDH1, slightly higher expression was observed within the stratum basalis. In disease progression, cytoplasmic ALDH1 expression showed a step-wise increase between endometrial hyperplasia, atypical hyperplasia, and endometrial cancer. ALDH1 was also shown to be an early predictor of EC development, suggesting that it can serve as an independent prognostic indicator of patients with endometrial hyperplasia with or without atypia who would progress to cancer (p=0.012).
引用
收藏
页数:11
相关论文
共 50 条
[31]   Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer [J].
Nalwoga, H. ;
Arnes, J. B. ;
Wabinga, H. ;
Akslen, L. A. .
BRITISH JOURNAL OF CANCER, 2010, 102 (02) :369-375
[32]   Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer [J].
H Nalwoga ;
J B Arnes ;
H Wabinga ;
L A Akslen .
British Journal of Cancer, 2010, 102 :369-375
[33]   TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF- ∼1 [J].
Kim, Yong Hun ;
Kim, Gwangil ;
Kwon, Chang-Il ;
Kim, Jong Woo ;
Park, Pil Won ;
Hahm, Ki-Baik .
ONCOLOGY REPORTS, 2014, 31 (03) :1380-1388
[34]   Association of CD133, ALDH1, CD117 and OCT4 expression with prognosis of patients with cervical cancer [J].
Almeida, Thais Aparecida Gomes ;
dos Santos, Odeony Paulo ;
Saddi, Vera Aparecida ;
Pereira, Jonathas Xavier ;
Machado, Helymar da Costa ;
Carneiro, Megmar Aparecida Santos ;
de Paula, Henrique Moura ;
Figueiredo-Alves, Rosane Ribeiro ;
Zeferino, Luiz Carlos ;
Rabelo-Santos, Silvia Helena .
VIRCHOWS ARCHIV, 2024, :791-801
[35]   Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer [J].
Wakamatsu, Yuta ;
Sakamoto, Naoya ;
Oo, Htoo Zarni ;
Naito, Yutaka ;
Uraoka, Naohiro ;
Anami, Katsuhiro ;
Sentani, Kazuhiro ;
Oue, Naohide ;
Yasui, Wataru .
PATHOLOGY INTERNATIONAL, 2012, 62 (02) :112-119
[36]   High Expression of c-Met, PKCλ and ALDH1A3 Predicts a Poor Prognosis in Late- stage Breast Cancer [J].
Motomura, Hitomi ;
Nozaki, Yuka ;
Onaga, Chotaro ;
Ozaki, Ayaka ;
Tamori, Shoma ;
Shiina, Taka-Aki ;
Kanai, Shotaro ;
Ohira, Chihiro ;
Hara, Yasushi ;
Harada, Yohsuke ;
Takasawa, Ryoko ;
Hanawa, Takehisa ;
Tanuma, Sei-Ichi ;
Mano, Yasunari ;
Sato, Tsugumichi ;
Sato, Keiko ;
Akimoto, Kazunori .
ANTICANCER RESEARCH, 2020, 40 (01) :35-52
[37]   High expression of WWP1 predicts poor prognosis and associates with tumor progression in human colorectal cancer [J].
Chen, Jian-Jun ;
Zhang, Wei .
AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (02) :256-265
[38]   SSH1 expression is associated with gastric cancer progression and predicts a poor prognosis [J].
Maimaiti, Yusufu ;
Maimaitiming, Maimaitiaili ;
Li, Yiliang ;
Aibibula, Saifuding ;
Ainiwaer, Azatijiang ;
Aili, Aikebaier ;
Sun, Zhenzhu ;
Abudureyimu, Kelimu .
BMC GASTROENTEROLOGY, 2018, 18
[39]   Correlations of Cancer Stem Cell-Related Markers CD44+/CD24-/low and ALDH1 Expression in Breast Cancer and Its Significance [J].
Fu, Yajun ;
Zhu, Juanying ;
Jiang, Xiaohong ;
Ren, Peng ;
Zhang, Xiongying ;
Xu, Guangtao .
PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON EDUCATION REFORM AND MODERN MANAGEMENT, 2014, 75 :185-188
[40]   Expression of ALDH1 in axillary lymph node metastases is a prognostic factor of poor clinical outcome in breast cancer patients with 1-3 lymph node metastases [J].
Nogami, Tomohiro ;
Shien, Tadahiko ;
Tanaka, Takehiro ;
Nishiyama, Keiko ;
Mizoo, Taeko ;
Iwamto, Takayuki ;
Ikeda, Hirokuni ;
Taira, Naruto ;
Doihara, Hiroyoshi ;
Miyoshi, Shinichiro .
BREAST CANCER, 2014, 21 (01) :58-65